This session will open with a conversation with Representative Anna Eshoo, followed by a panel discussion on ARPA-H.

The signature achievements of the federal Defense Advanced Research Projects Agency (DARPA) are well known. Among them were early iterations of the internet, wireless communication, speech recognition, and global positioning systems. More than a decade of advocacy for a similar agency targeting high-risk, high-reward innovations in health has borne fruit in the creation of the Advanced Research Projects Agency for Health (ARPA-H) in 2022. What problems should this new entity focus on solving? How should ARPA-H be structured if it is to achieve the same quality of breakthroughs as DARPA?

Guest

Anna Eshoo
US Representative, California; Chair, US House Energy and Commerce Subcommittee on Health

Moderators

Margaret Anderson
Managing Director, Deloitte

Esther Krofah
Executive Vice President, MI Health, Milken Institute

Speakers

Christopher Austin
CEO and Partner, Flagship Pioneering

Howard Fillit
Co-Founder and Chief Science Officer, Alzheimer's Drug Discovery Foundation

Susan Monarez
Acting Deputy Director, Advanced Research Projects Agency for Health (ARPA-H)

Tara Schwetz
Acting Principal Deputy Director, National Institutes of Health

Michael Stebbins
President, Science Advisors